Skip to content

Drug interactions

Brentuximab + Trastuzumab deruxtecan

Severity: Moderate

Brentuximab and Trastuzumab deruxtecan: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both agents are cytotoxic antibody-drug conjugates that cause myelosuppression, so combining them may deepen neutropenia and raise infection risk. Trastuzumab deruxtecan also carries a risk of interstitial lung disease.

What this interaction means in plain words

Brentuximab and Trastuzumab deruxtecan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Brentuximab belongs to Oncology; Trastuzumab deruxtecan belongs to Oncology.

Evidence level: Low

Why it happens

Additive bone marrow suppression from the cytotoxic payloads of both antibody-drug conjugates.

What to do

Monitor complete blood counts frequently and for signs of infection, and use growth factor support or dose delays according to neutropenia grade.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Brentuximab and Trastuzumab deruxtecan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Brentuximab with Trastuzumab deruxtecan?

MediHelp rates the interaction as moderate. Brentuximab and Trastuzumab deruxtecan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both agents are cytotoxic antibody-drug conjugates that cause myelosuppression, so combining them may deepen neutropenia and raise infection risk. Trastuzumab deruxtecan also carries a risk of interstitial lung disease.

How serious is the interaction between Brentuximab and Trastuzumab deruxtecan?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor complete blood counts frequently and for signs of infection, and use growth factor support or dose delays according to neutropenia grade.

What other medicines interact with Brentuximab?

MediHelp also lists interactions of Brentuximab with, for example, Bleomycin, Dengue vaccine, Etrasimod. The full list is on the Brentuximab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in